EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Symphony of Mitophagy: Ubiquitin‐Specific Protease‐30 as a Maestro for Precision Management of Neurodegenerative Diseases

Ankit Siwach, Harit Patel, Amit Khairnar, Pathik Parekh iD

CNS Neuroscience & Therapeutics · 2025

DOI: 10.1111/cns.70192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Ankit Siwach und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gujarat, India. Hauptthemen laut MEDLINE: Mitophagy, Neurodegenerative Diseases, Precision Medicine, Thiolester Hydrolases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union: NextGenerationEU, National Institute of Pharmaceutical Education and Research (NIPER) seed fund-Ahmedabad, Department of Pharmaceutics, Ministry of Chemicals and Fertilizers, Go…, Ramalingaswami fellowship, Department of Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mitochondrial dysfunction stands as a pivotal feature in neurodegenerative disorders, spurring the quest for targeted therapeutic interventions. This review examines Ubiquitin‐Specific Protease 30 (USP30) as a master regulator of mitophagy with therapeutic promise in Alzheimer's disease (AD) and Parkinson's disease (PD). USP30's orchestration of mitophagy pathways, encompassing PINK1‐dependent and PINK1‐independent mechanisms, forms the crux of this exploration.

Method

A systematic literature search was conducted in PubMed, Scopus, and Web of Science, selecting studies that investigated USP's function, inhibitor design, or therapeutic efficacy in AD and PD. Inclusion criteria encompassed mechanistic and preclinical/clinical data, while irrelevant or duplicate references were excluded. Extracted findings were synthesized narratively.

Results

USP30 modulates interactions with translocase of outer mitochondrial membrane (TOM) 20, mitochondrial E3 ubiquitin protein ligase 1 (MUL1), and Parkin, thus harmonizing mitochondrial quality control. Emerging novel USP30 inhibitors, racemic phenylalanine derivatives, N‐cyano pyrrolidine, and notably, benzosulphonamide class compounds, restore mitophagy, and reduce neurodegenerative phenotypes across diverse models with minimal off‐target effects. Modulation of other USPs also influences neurodegenerative disease pathways, offering additional therapeutic avenues.

Conclusions

In highlighting the nuanced regulation of mitophagy by USP30, this work heralds a shift toward more precise and effective treatments, paving the way for a new era in the clinical management of neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyNeurodegenerative DiseasesPrecision MedicineThiolester HydrolasesHumansAnimalsMitochondrial ProteinsMitochondria

Stichwörter der Autor:innen

Alzheimer's diseaseParkinson's diseaseUSP13 inhibitorsUSP14 inhibitorsUSP30 inhibitorsdeubiquitinating enzymesmitophagyubiquitin‐specific protease

Substanzen

Usp30 protein, humanMitochondrial ProteinsThiolester Hydrolases

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gujarat, India.
  • School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan, India.
  • Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • International Clinical Research Center (ICRC), St. Anne's University Hospital, Brno, Czech Republic.
  • International Clinical Research Center (ICRC), Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, USA.

ORCID-Profile: Pathik Parekh

Förderung

  • European Union: NextGenerationEU
  • National Institute of Pharmaceutical Education and Research (NIPER) seed fund-Ahmedabad, Department of Pharmaceutics, Ministry of Chemicals and Fertilizers, Go…
  • Ramalingaswami fellowship, Department of Biotechnology

Zitieren

APA

Siwach, A., Patel, H., Khairnar, A., & Parekh, P. (2025). Molecular Symphony of Mitophagy: Ubiquitin‐Specific Protease‐30 as a Maestro for Precision Management of Neurodegenerative Diseases. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70192

Vancouver

Siwach A, Patel H, Khairnar A, Parekh P. Molecular Symphony of Mitophagy: Ubiquitin‐Specific Protease‐30 as a Maestro for Precision Management of Neurodegenerative Diseases. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70192

BibTeX
@article{Siwach2025,
  author = {Siwach, Ankit and Patel, Harit and Khairnar, Amit and Parekh, Pathik},
  title = {Molecular Symphony of Mitophagy: Ubiquitin‐Specific Protease‐30 as a Maestro for Precision Management of Neurodegenerative Diseases},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  doi = {10.1111/cns.70192}
}
Kostenlos starten →